Anticancer Activity and High Content Screening of New 6-Substituted-5,6-dihydrobenzo[4,5]imidazo[1,2-c]quinazoline Derivatives.

Hiba Ali Hasan; Afrah Salman; Emilia Abdulmalek

doi:10.52711/0974-360X.2021.00423

Research Journal of Pharmacy and Technology

ISSN

0974-360X (Online)
0974-3618 (Print)

Submit Article

Anticancer Activity and High Content Screening of New 6-Substituted-5,6-dihydrobenzo[4,5]imidazo[1,2-c]quinazoline Derivatives.

Author(s): Hiba Ali Hasan, Afrah Salman, Emilia Abdulmalek

Email(s): hibaalichemist@uomustansiriyah.edu.iq

DOI: 10.52711/0974-360X.2021.00423

Address: Hiba Ali Hasan1*, Afrah Salman2, Emilia Abdulmalek3,4
1Department of Pharmacognosy and Medicinal Plants, College of Pharmacy, Mustansiriyah University, Baghdad, Iraq.
Department of Pharmacology and Toxicology, College of Pharmacy, Mustansiriyah University, Baghdad, Iraq
3Department of Chemistry, Faculty of Science, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia.
4Integrated Chemical BioPhysics Research, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia.
*Corresponding Author

Published In: Volume - 14, Issue - 5, Year - 2021

Keywords:

Cite this article:
Hiba Ali Hasan, Afrah Salman, Emilia Abdulmalek. Anticancer Activity and High Content Screening of New 6-Substituted-5,6-dihydrobenzo[4,5]imidazo[1,2-c]quinazoline Derivatives. Research Journal of Pharmacy and Technology. 2021; 14(5):2397-5. doi: 10.52711/0974-360X.2021.00423

View PDF